Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions

被引:80
作者
Watson, AMD
Lambert, GW
Smith, KJ
May, CN [1 ]
机构
[1] Univ Melbourne, Howard Florey Inst, Melbourne, Vic 3010, Australia
[2] Baker Heart Res Inst, Melbourne, Vic, Australia
关键词
cardiac output; adrenocorticotropic hormone; glucose; hemodynamics; urotensin; sheep;
D O I
10.1161/01.HYP.0000084633.85427.E6
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Urotensin II is a small peptide whose receptor was recently identified in mammals as the orphan G protein - coupled receptor-14. The reported cardiovascular responses to systemic urotensin II administration are variable, and there is little detailed information on its central cardiovascular actions. We examined the cardiovascular and humoral actions of intracerebroventricular urotensin II (0.02 and 0.2 nmol/kg and vehicle) and intravenous urotensin II ( 2, 20, and 40 nmol/kg and vehicle) in conscious ewes previously surgically implanted with flow probes and intracerebroventricular guide tubes. Two hours after intracerebroventricular infusion of urotensin II ( 0.2 nmol/kg over 1 hour; n = 5), heart rate ( + 56 +/- 13 beats per minute [bpm]), dF/dt ( an index of cardiac contractility; + 533 +/- 128 L . min(-1) . s(-1)), and cardiac output ( + 3.4 +/- 0.4 L/min) increased significantly compared with vehicle, as did renal, mesenteric, and iliac blood flows and conductances. Plasma epinephrine, adrenocorticotropic hormone, and glucose levels also increased dramatically ( + 753 +/- 166 pg/mL, + 14.3 +/- 3.5 pmol/L, and + 7.0 +/- 1.4 mmol/L, respectively). All of these variables remained elevated for up to 4 hours after infusion. In contrast, 1 hour after intravenous urotensin II (40 nmol/kg bolus; n = 6), a sustained tachycardia ( + 25 +/- 8 bpm) ensued, but cardiac output, cardiac contractility, total peripheral conductance, and plasma glucose levels did not change significantly. In summary, this is the first study to show that urotensin II acts centrally to stimulate sympathoadrenal and pituitary-adrenal pathways, resulting in increased adrenocorticotropic hormone and epinephrine release and potent chronotropic and inotropic actions. In contrast, tachycardia was the only major response to intravenous urotensin II. These findings suggest that urotensin II is a novel stimulator of central pathways that mediate responses to alerting stimuli or stress.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 34 条
  • [1] No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans
    Affolter, JT
    Newby, DE
    Wilkinson, IB
    Winter, MJ
    Balment, RJ
    Webb, DJ
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (06) : 617 - 621
  • [2] Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
    Ames, RS
    Sarau, HM
    Chambers, JK
    Willette, RN
    Alyar, NV
    Romanic, AM
    Louden, CS
    Foley, JJ
    Sauermelch, CF
    Coatney, RW
    Ao, ZH
    Disa, J
    Holmes, SD
    Stadel, JM
    Martin, JD
    Liu, WS
    Glover, GI
    Wilson, S
    McNulty, DE
    Ellis, CE
    Elshourbagy, NA
    Shabon, U
    Trill, JJ
    Hay, DWP
    Ohlstein, EH
    Bergsma, DJ
    Douglas, SA
    [J]. NATURE, 1999, 401 (6750) : 282 - 286
  • [3] DIFFERENTIAL REGIONAL HEMODYNAMIC-EFFECTS OF CORTICOTROPIN IN CONSCIOUS SHEEP
    BEDNARIK, JA
    MAY, CN
    [J]. HYPERTENSION, 1994, 24 (01) : 49 - 55
  • [4] Urotensin II evokes potent vasoconstriction in humans in vivo
    Böhm, F
    Pernow, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) : 25 - 27
  • [5] The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat
    Clark, SD
    Nothacker, HP
    Wang, Z
    Saito, Y
    Leslie, FM
    Civelli, O
    [J]. BRAIN RESEARCH, 2001, 923 (1-2) : 120 - 127
  • [6] Conlon JM, 1996, J EXP ZOOL, V275, P226, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<226::AID-JEZ14>3.0.CO
  • [7] 2-H
  • [8] Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord
    Coulouarn, Y
    Lihrmann, I
    Jegou, S
    Anouar, Y
    Tostivint, H
    Beauvillain, JC
    Conlon, JM
    Bern, HA
    Vaudry, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15803 - 15808
  • [9] Solid-phase synthesis of ovine Leydig cell insulin-like peptide - a putative ovine relaxin?
    Dawson, NF
    Tan, YY
    Macris, M
    Otvos, L
    Summers, RJ
    Tregear, GW
    Wade, JD
    [J]. JOURNAL OF PEPTIDE RESEARCH, 1999, 53 (05): : 542 - 547
  • [10] Inhibition of prostaglandin and nitric oxide synthesis prevents cortisol-induced renal vasodilatation in sheep
    De Matteo, R
    May, CN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 276 (04) : R1125 - R1131